Share Information

Stock option plans total: 1,435,845 (see below for details)

Remaining total amount of option rights (as of 31 March 2026): 1,300,438

Other

Board of Directors authorizations outstanding total: 1,530,000 shares (see below extracts from AGM 2026 decisions)

THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS RESOLVED TO AUTHORIZE THE BOARD OF DIRECTORS TO DECIDE ON (I) THE ISSUANCE OF NEW SHARES AND/OR (II) THE TRANSFER OF THE COMPANY'S OWN SHARES HELD BY THE COMPANY AND/OR (III) THE GRANTING OF SPCIEL RIGHTS REFERRED TO IN CHAPTER 10, SECTION 1 OF THE FINNISH COMPANIES ACT, ON THE FOLLOWING TERMS AND CONDITIONS:

Right to shares: 

New shares may be issued and the Company's own shares held by the Company may be transferred 

• to the Company's shareholders in proportion to their existing shareholdings in the Company; or 

• by way of a directed share issue deviating from the shareholders' pre-emptive right, if there is a weighty financial reason for the Company to do so, such as using the shares as consideration in possible acquisitions or other arrangements pertaining to the Company's business operations, or financing investments. 

New shares may also be issued as a free share issue to the Company itself. Share issue against payment and free share issue: New shares may be issued and the Company's own shares held by the Company may be transferred either against payment (Share issue against payment) or free of charge (Free share issue). A directed share issue may be free of charge only if there is an especially weighty financial reason for the Company to do so, taking into account the interests of all shareholders of the Company. 

Maximum number of shares: 

Under the authorisation, the Board of Directors is entitled to decide on the issuance of new shares and/or the transfer of the Company's own shares held by the Company so that the total number of shares to be issued and/or transferred shall not exceed 1,400,000 shares, which corresponds to approximately 16.25 per cent of all shares in the Company after the share issue, if new shares are issued, taking into account all registered shares of the Company. 

Granting of special rights: 

The Board of Directors may grant special rights referred to in Chapter 10, Section 1 of the Finnish Companies Act, which entitle the holder to receive, against payment, new shares or the Company's own shares held by the Company. The right may also be granted to a creditor of the Company so that the right includes a condition that the creditor's receivable may be used to set off the subscription price of the shares (convertible bond). 

The total number of new shares to be subscribed and the Company's own shares held by the Company to be transferred under the special rights granted by the Company shall not exceed 1,400,000 shares, which number is included in the maximum number referred to above under "Maximum number of shares". 

Recording of the subscription price in the balance sheet: 

The subscription price of new shares and the amount payable for the Company's own shares shall be recorded in the reserve for invested unrestricted equity. 

Other terms and validity: 

The Board of Directors shall decide on all other matters related to the authorisations. The authorisations shall be valid until the next Annual General Meeting, commencing from the date of the resolution of this Annual General Meeting. 

THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS RESOLVED TO AUTHORIZE THE BOARD OF DIRECTORS TO DECIDE ON (I) THE ISSUANCE OF NEW SHARES AND/OR (II) THE TRANSFER OF THE COMPANY'S OWN SHARES HELD BY THE COMPANY AND/OR (III) THE GRANTING OF SPCIEL RIGHTS REFERRED TO IN CHAPTER 10, SECTION 1 OF THE FINNISH COMPANIES ACT, ON THE FOLLOWING TERMS AND CONDITIONS:

The shares to be issued under the authorisation shall be new shares of the Company or shares held by the Company. Under and within the limits of the authorisation, the Board of Directors may also decide on the granting of stock options or other special rights pursuant to Chapter 10 of the Finnish Companies Act alongside or instead of the issuance of shares. New shares may also be issued as a free share issue to the Company itself. 

Share issue against payment and free share issue: 

New shares may be issued and the Company's own shares held by the Company may be transferred either against payment (Share issue against payment) or free of charge (Free share issue). A directed share issue may be free of charge only if there is an especially weighty financial rea-son for the Company to do so, taking into account the interests of all shareholders of the Company. 

The total number of shares to be issued under the authorisation shall not exceed 130,000 shares. This number corresponds to approximately 1.77 per cent of all shares in the Company after the share issue, if new shares are issued, taking into account all registered shares of the Company. 

Shares, stock options and/or special rights entitling to shares may be issued in one or more tranches. The Board of Directors is authorised to decide on all terms and conditions of the share issue as well as the terms and conditions of the granting of stock options and special rights. 

The Board of Directors is authorised to decide on a directed share issue and to grant special rights entitling to shares and to deviate from the shareholders' pre-emptive right to subscribe for shares, provided that the Company has a weighty financial reason to do so. 

The authorisation shall be valid for five (5) years from the resolution of the Annual General Meeting. The authorisation may be used for the implementation of long-term incentive plans for the members of the Board of Directors and the Company's management and personnel. The authorisation may also be used for arranging incentives and for the payment of Board remuneration. 

The authorisations do not revoke previously granted and registered authorisations to decide on the issuance of shares and the granting of special rights entitling to shares or the granting of stock options.